These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 12176593)

  • 21. New immunosuppressive agents in clinical use: mycophenolate mofetil and tacrolimus.
    Hunt SA
    Cardiol Rev; 2000; 8(3):180-4. PubMed ID: 11174892
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mycophenolate mofetil/Neoral/steroid vs Neoral/steroid therapy for prophylaxis of acute rejection in renal transplant recipients.
    Carmellini M; Vistoli F; Bellini R; Boggi U; Rindi P; Rizzo G; Mosca F
    Transplant Proc; 1999; 31(1-2):1162-4. PubMed ID: 10083519
    [No Abstract]   [Full Text] [Related]  

  • 23. Low doses of mycophenolate mofetil with low doses of tacrolimus prevent acute rejection and long-term function loss after lung transplantation.
    Gerbase MW; Spiliopoulos A; Fathi M; Nicod LP
    Transplant Proc; 2001 May; 33(3):2146-7. PubMed ID: 11377481
    [No Abstract]   [Full Text] [Related]  

  • 24. Review of major clinical trials with mycophenolate mofetil in cardiac transplantation.
    Kobashigawa JA; Meiser BM
    Transplantation; 2005 Oct; 80(2 Suppl):S235-43. PubMed ID: 16251856
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators.
    Kobashigawa J; Miller L; Renlund D; Mentzer R; Alderman E; Bourge R; Costanzo M; Eisen H; Dureau G; Ratkovec R; Hummel M; Ipe D; Johnson J; Keogh A; Mamelok R; Mancini D; Smart F; Valantine H
    Transplantation; 1998 Aug; 66(4):507-15. PubMed ID: 9734496
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mycophenolate mofetil with lower cyclosporine dose in high-risk renal transplant recipients.
    Esmeraldo RM; Donadi MO; Oliveira ML; Ponte CN; Pinheiro PM
    Transplant Proc; 1999 Nov; 31(7):3007-8. PubMed ID: 10578367
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of mycophenolate mofetil in heart transplantation.
    Mathieu P; Carrier M; White M; Pellerin M; Perrault L; Pelletier G; Robitaille D; Pelletier LC
    Can J Surg; 2000 Jun; 43(3):202-6. PubMed ID: 10851414
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Conversion of liver transplant recipients on cyclosporine with renal impairment to mycophenolate mofetil.
    Herrero JI; Quiroga J; Sangro B; Girala M; Gómez-Manero N; Pardo F; Alvárez-Cienfuegos J; Prieto J
    Liver Transpl Surg; 1999 Sep; 5(5):414-20. PubMed ID: 10477843
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: long-term follow-up of the SHIRAKISS randomized, prospective study.
    Potena L; Prestinenzi P; Bianchi IG; Masetti M; Romani P; Magnani G; Fallani F; Coccolo F; Russo A; Ponticelli C; Rapezzi C; Grigioni F; Branzi A
    J Heart Lung Transplant; 2012 Jun; 31(6):565-70. PubMed ID: 22341702
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mycophenolate mofetil, along with ATG and cyclosporine, significantly lowers the incidence of acute rejection episodes in renal transplant recipients.
    Puig JM; Lloveras J; Fernández-Crespo P; Mir M; Iñigo V; Manresa JM; Masramón J
    Transplant Proc; 1999 Sep; 31(6):2259-60. PubMed ID: 10500567
    [No Abstract]   [Full Text] [Related]  

  • 31. Mycophenolate mofetil, ATG, and cyclosporine in the induction treatment of renal transplant recipients minimizes the incidence of acute rejection episodes.
    Puig JM; Lloveras J; Fernández-Crespo P; Mir M; Marcas LI; Manresa JM; Masramón J
    Transplant Proc; 1998 Aug; 30(5):2226-7. PubMed ID: 9723449
    [No Abstract]   [Full Text] [Related]  

  • 32. Place of mycophenolate mofetil in renal transplantation.
    Grinyó JM
    Transplant Proc; 2001; 33(1-2):997-9. PubMed ID: 11267162
    [No Abstract]   [Full Text] [Related]  

  • 33. Mycophenolate mofetil (RS-61443): preclinical, clinical, and three-year experience in heart transplantation.
    Taylor DO; Ensley RD; Olsen SL; Dunn D; Renlund DG
    J Heart Lung Transplant; 1994; 13(4):571-82. PubMed ID: 7947873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The treatment of chronic rejection with mycophenolate mofetil versus azathioprine in kidney transplantation.
    Jirasiritham S; Sumethkul V; Mavichak V; Chalermsanyakorn P
    Transplant Proc; 2000 Nov; 32(7):2040-2. PubMed ID: 11120057
    [No Abstract]   [Full Text] [Related]  

  • 35. Postmarketing evaluation of mycophenolate mofetil-based triple therapy immunosuppression compared with a conventional azathioprine-based regimen reveals enhanced efficacy and early pharmacoeconomic benefit after renal transplantation.
    Wüthrich RP; Weinreich T; Schwarzkopf AK; Candinas D; Binswanger U
    Transplant Proc; 1998 Dec; 30(8):4096-7. PubMed ID: 9865310
    [No Abstract]   [Full Text] [Related]  

  • 36. Mycophenolate mofetil in cardiac transplantation.
    Kobashigawa JA
    Curr Opin Cardiol; 1998 Mar; 13(2):117-21. PubMed ID: 9593551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial.
    Remuzzi G; Lesti M; Gotti E; Ganeva M; Dimitrov BD; Ene-Iordache B; Gherardi G; Donati D; Salvadori M; Sandrini S; Valente U; Segoloni G; Mourad G; Federico S; Rigotti P; Sparacino V; Bosmans JL; Perico N; Ruggenenti P
    Lancet; 2004 Aug 7-13; 364(9433):503-12. PubMed ID: 15302193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single center analysis of mycophenolate mofetil and Neoral/prednisone therapy for prophylaxis of rejection in African-American and Caucasian transplant recipients.
    Weber M; Ketchum RJ; Sellers M; Aradhye S; Deng S; Grossman R; Shaw L; Naji A; Barker C; Brayman KL
    Transplant Proc; 1997; 29(1-2):338-9. PubMed ID: 9123029
    [No Abstract]   [Full Text] [Related]  

  • 39. Tacrolimus and azathioprine versus cyclosporine and mycophenolate mofetil after lung transplantation: a retrospective cohort study.
    Celik MR; Lederer DJ; Wilt J; Eser D; Bacchetta M; D'Ovidio F; Sonett JR; Arcasoy SM
    J Heart Lung Transplant; 2009 Jul; 28(7):697-703. PubMed ID: 19560698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lymphocyte subsets in renal transplant recipients treated with mycophenolate mofetil.
    François M; Büchler M; Halimi JM; Al-Najjar A; Valentin JF; Thibault G; Lebranchu Y
    Transplant Proc; 2000 Dec; 32(8):2781-2. PubMed ID: 11134803
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.